Merck KGaA’s Life‑Science‑Division Unveils the Curiosity‑Cube‑Tour 2026
Merck KGaA’s Life‑Science‑Division, operating under the brand MilliporeSigma, has formally announced the launch of its global Curiosity‑Cube‑Tour 2026. This initiative will deploy a mobile laboratory—designed to operate within schools and universities across North America, Europe, and South Africa—to deliver immersive, hands‑on STEM education.
The program is an integral component of the company’s expansive engagement strategy, aimed at fostering a pipeline of talent for the life‑science sector. By enabling direct interaction with state‑of‑the‑art technologies, the Curiosity‑Cube‑Tour will demonstrate the practical applications of synthetic biology, enzymology, DNA encoding, and gene activation.
Over the course of the year, more than 1,300 events will be conducted, reaching tens of thousands of students. This scale of outreach underscores Merck’s unwavering commitment to scientific public outreach and to nurturing the future workforce. The tour not only serves as an educational platform but also reinforces the company’s dedication to sustainability, social business innovation, and the promotion of careers within the life‑science arena.
These developments signal Merck’s strategic positioning at the intersection of cutting‑edge research and workforce development. The Curiosity‑Cube‑Tour represents a forward‑looking investment in the next generation of scientists, engineers, and innovators—an investment that aligns seamlessly with the company’s long‑term vision of driving global health and scientific advancement.
